277
Participants
Start Date
February 2, 2021
Primary Completion Date
November 21, 2022
Study Completion Date
January 30, 2026
Patritumab Deruxtecan (Fixed dose)
Patritumab deruxtecan will be dosed at 5.6 mg/kg as an intravenous (IV) infusion administered on Day 1 of each 21-day cycle.
Patritumab Deruxtecan (Up-Titration)
Patritumab deruxtecan will be dosed as an intravenous (IV) infusion administered at Cycle 1, 3.2 mg/kg; Cycle 2, 4.8 mg/kg; Cycle 3 and subsequent cycles, 6.4 mg/kg administered on Day 1 of each 21-day cycle.
National Taiwan University Hospital NTUH, Taipei
Chang Gung Memorial Hospital - Linkou Branch, Taoyuan District
Chung Shan Medical University Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
E-Da Hospital, Kaohsiung City
Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf, Vienna
MHAT Serdika, Sofia
The Chris O'Brien Lifehouse, Camperdown
Blacktown Hospital, Blacktown
St George Public Hospital, Kogarah
Peter MacCallum Cancer Centre, Melbourne
Universitaire Ziekenhuis Gasthuisberg, Leuven
Princess Alexandra Hospital, Woolloongabba
MHAT Uni Hospital OOD, Panagyurishte
St John of God Subiaco Hospital, Subiaco
Complex Oncological Center - Russe, Rousse
Mount Sinai Hospital, New York
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano
Memorial Sloan Kettering Cancer Center, New York
National Cancer Center, Goyang-si
MacKay Memorial Hospital, Taipei
Montefiore Medical Center, The Bronx
Seoul National University Bundang Hospital, Seongnam
Humanitas Cancer Center, Rozzano
Fondazione IRCCS Istituto Nazionale Tumori, Milan
University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore
Virginia Cancer Specialist, PC, Fairfax
University of Virginia Cancer Center - Emily Couric Clinical Cancer Center, Charlottesville
LungenClinic Grosshansdorf, Großhansdorf
MD Anderson Cancer Center, Madrid
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
START Madrid - Hospital Universitario HM Sanchinarro, Madrid
Levine Cancer Institute, Charlotte
Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda
Chungbuk National University Hospital, Cheongju-si
Hospital Regional Universitario Carlos Haya, Málaga
Hopital Morvan CHU de Brest, Brest
Emory University, Dunwoody
CHU Toulouse - Hopital Larrey, Toulouse
Florida Cancer Specialists-Panhandle, Tallahassee
AdventHealth Orlando, Orlando
Memorial Healthcare System, Pembroke Pines
Florida Cancer Specialists-East, West Palm Beach
H. Lee Moffitt Cancer Center & Research Institute, Tampa
Florida Cancer Specialist-North, St. Petersburg
Florida Cancer Specialists - South, Fort Myers
Hopital Pontchaillou, Rennes
Sarah Cannon Research Institute, Nashville
Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga, Chattanooga
Centre Hospitalier Universitaire de Grenoble, Grenoble
Taichung Veterans General Hospital, Taichung
Hospital Universitario Virgen Macarena, Seville
Kyungpook National University Chilgok Hospital, Daegu
Azienda Ospedaliero Universitaria di Parma, Parma
University Hospital of Nantes - Thoracic Oncology, Nantes
Cleveland Clinic - Main Campus, Cleveland
IRCCS - Istituto Scientifico Romagnolo per lo Studio e La Cura Dei Tumori ISRT, Meldola
Henry Ford Cancer Institute/Henry Ford Hospital, Detroit
Hospital Clinico Universitario Lozano Bleza, Zaragoza
Universitaet zu Koeln - Uniklinik Koeln, Cologne
Universitaet zu Koeln - Uniklinik Koeln, Cologne
Kliniken der Stadt Koeln gGmbH Lungenklinik Merheim, Cologne
Kliniken der Stadt Koeln gGmbH Lungenklinik Merheim, Cologne
Northwestern University, Chicago
Centre Leon Berard, Lyon
Institut Curie, Paris
University of Colorado Denver - Anschutz Medical Campus, Aurora
Chang Gung Memorial Hospital CGMH - Kaohsiung Branch, Niaosong
Banner MD Anderson Cancer Center, Gilbert
USC Norris Comprehensive Cancer Center, Los Angeles
Cedars Sinai, West Hollywood
Pacific Shores Medical Group, Long Beach
City of Hope, Duarte
Moores Cancer Center at the UC San Diego Health, La Jolla
University of California at Irvine, Orange
Gustave Roussy, Villejuif
Providence Portland Medical Center, Portland
University of Washington/Seattle Cancer Care Alliance, Seattle
Beijing Cancer Hospital, Beijing
The First Hospital of China Medical University, Shenyang
National University Cancer Institute National University Hospital, Singapore
Jilin Cancer Hospital, Changchun
Harbin Medical University - Tumor Hospital (The Third Affiliated Hospital), Harbin
National Cancer Centre Singapore NCCS, Singapore
Fudan University - Shanghai Cancer Center FUSCC, Shanghai
General Hospital of Eastern Theater Command, Nanjing
OncoCare Cancer Centre- Gleneagles Medical Centre, Singapore
The First Affiliated Hospital of College of Medicine Zhejiang University, Hangzhou
Union Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan
Henan Cancer Hospital, Zhengzhou
Guangdong Academy of Medical Science (GAMS) - Guangdong Provincial Peoples Hospital, Guangzhou
University of Electronic Science & Technology of China (UESTC) - Sichuan Cancer Hospital & Institute (Sichuan Provincial Tumor Hospital, Chengdu
Massachusetts General Hospital (MGH) - Hematology/Oncology, Boston
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston
Dana-Farber Cancer Institute, Boston
University Cancer Center, Dresden
National Cancer Center Hospital East, Kashiwa
National Cancer Center Hospital, Tokyo
National Cancer Center Hospital, Chuo Ku
National Hospital Organization Shikoku Cancer Center, Matsuyama
National Hospital Organization Hokkaido Cancer Center, Sapporo
National Hospital Organization Hokkaido Cancer Center, Sapporo
Hyogo Cancer Center, Akashi
National Cancer Center Hospital East, Chiba
The Cancer Institute Hospital of JFCR, Ariake
Sendai Kousei Hospital, Sendai
Kansai Medical University Hospital, Hirakata
Kindai University Hospital, Ōsaka-sayama
Shizuoka Cancer Center, Nagaizumi-chō
Niigata Cancer Center Hospital, Chūōku
National Hospital Organization Kyushu Cancer Center, Fukuoka
Netherlands Cancer Institute, Amsterdam
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea, Seoul St. Marys Hospital, Seoul
Catalan Institute of Badalona Hospital Germans Trias i Pujol ICO, Badalona
Hospital Universitario Vall d'Hebron, Barcelona
University Hospital Birmingham NHS Trust, Birmingham
The Royal Marsden NHS Foundation Trust, London
University College London Hospitals, London
The Christie Hospital, Manchester
Lead Sponsor
Collaborators (1)
Daiichi Sankyo Co., Ltd.
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY
Daiichi Sankyo
INDUSTRY